SML3852

Saroglitazar Magnesium

≥98% (HPLC)

• Synonym(e): (αS)-α-Ethoxy-4-[2-[2-methyl-5-[4-(methylthio)phenyl]-1H-pyrrol-1-yl]ethoxy]benzenepropanoic acid Magnesium, (s)-2-Ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy)phenyl)propanoic acid Magnesium
• Empirische Formel (Hill-System): C₅₀H₅₆MgN₂O₈S₂
• CAS-Nummer: 1639792-20-3
• Molekulargewicht: 901.42
• UNSPSC Code: 12352200
• NACRES: NA.77
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear (Warmed)
• storage temp.: -10 to -25°C
• SMILES string: [Mg+2].S(C)c4ccc(cc4)c5[n](c(cc5)C)CCOc6ccc(cc6)C[C@H](OCC)C(=O)[O-].S(C)c1ccc(cc1)c2[n](c(cc2)C)CCOc3ccc(cc3)C[C@H](OCC)C(=O)[O-]
• InChI: 1S/2C25H29NO4S.Mg/c2*1-4-29-24(25(27)28)17-19-6-10-21(11-7-19)30-16-15-26-18(2)5-14-23(26)20-8-12-22(31-3)13-9-20;/h2*5-14,24H,4,15-17H2,1-3H3,(H,27,28);/q;;+2/p-2/t2*24-;/m00./s1
• InChI key: UJYFZCVPOSZDMK-YPPDDXJESA-L

Beschreibung

Biochem/physiol Actions

Potent and selective PPARα/γ agonist.

Saroglitazar is a potent and selective PPARα/γ (peroxisome proliferator-activated receptor) agonist that exhibits lipid-lowering and insulin-sensitizing effects. Saroglitazar is approved in India for the treatment of diabetes type 2 and dyslipidemia.

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• Was ist los?: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable